Description

TAB-FPNM-CV is a combination antibacterial formulation containing Faropenem and Potassium Clavulanate. Faropenem acts by inhibiting bacterial cell wall synthesis, while Potassium Clavulanate is a beta-lactamase inhibitor. The combination is intended for prescription-based management of bacterial infections where its use is clinically appropriate. Treatment selection should consider the suspected or confirmed bacteria and applicable antibiotic guidelines. Aslan Healthcare emphasizes product quality and appropriate pharmaceutical manufacturing standards. This medicine should be taken strictly according to medical advice.